160 related articles for article (PubMed ID: 27290673)
1. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry.
Lesiak M; Łanocha M; Araszkiewicz A; Siniawski A; Grygier M; Pyda M; Olasińska-Wiśniewska A; Iwanczyk S; Skorupski W; Mitkowski P; Lesiak MB; Grajek S
EuroIntervention; 2016 Jun; 12(2):e144-51. PubMed ID: 27290673
[TBL] [Abstract][Full Text] [Related]
2. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.
Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A
EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833
[TBL] [Abstract][Full Text] [Related]
3. Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions.
Fam JM; Ojeda S; Garbo R; Latib A; La Manna A; Vaquerizo B; Boukhris M; Vlachojannis GJ; van Geuns RJ; Ezhumalai B; Kawamoto H; van der Sijde J; Felix C; Pan M; Serdoz R; Boccuzzi GG; De Paolis M; Sardella G; Mancone M; Tamburino C; Smits PC; Di Mario C; Seth A; Serra A; Colombo A; Serruys P; Galassi AR; Zijlstra F; Van Mieghem NM; Diletti R
EuroIntervention; 2017 Jun; 13(3):355-363. PubMed ID: 28218604
[TBL] [Abstract][Full Text] [Related]
4. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold (BVS) Implantation in Patients With Chronic Total Coronary Occlusions: Acute Procedural and Short-Term Clinical Results.
Goktekin O; Yamac AH; Latib A; Tastan A; Panoulas VF; Sato K; Erdogan E; Uyarel H; Shah I; Colombo A
J Invasive Cardiol; 2015 Oct; 27(10):461-6. PubMed ID: 26429848
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion.
Wiebe J; Liebetrau C; Dörr O; Most A; Weipert K; Rixe J; Bauer T; Möllmann H; Elsässer A; Hamm CW; Nef HM
Int J Cardiol; 2015 Jan; 179():90-4. PubMed ID: 25464422
[TBL] [Abstract][Full Text] [Related]
7. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry.
La Manna A; Miccichè E; D'Agosta G; Tensol Rodrigues Pereira G; Attizzani GF; Capranzano P; Capodanno D; Tamburino C
Int J Cardiol; 2018 Feb; 253():45-49. PubMed ID: 29137819
[TBL] [Abstract][Full Text] [Related]
8. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.
Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR
Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
Capodanno D; Gori T; Nef H; Latib A; Mehilli J; Lesiak M; Caramanno G; Naber C; Di Mario C; Colombo A; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Pyxaras S; Mattesini A; Naganuma T; Münzel T; Tamburino C
EuroIntervention; 2015 Feb; 10(10):1144-53. PubMed ID: 25042421
[TBL] [Abstract][Full Text] [Related]
10. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.
Muramatsu T; Onuma Y; García-García HM; Farooq V; Bourantas CV; Morel MA; Li X; Veldhof S; Bartorelli A; Whitbourn R; Abizaid A; Serruys PW;
JACC Cardiovasc Interv; 2013 Mar; 6(3):247-57. PubMed ID: 23517836
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and computed tomography scan follow-up of bioresorbable vascular scaffold for the percutaneous treatment of chronic total coronary artery occlusion.
Ojeda S; Pan M; Romero M; Suárez de Lezo J; Mazuelos F; Segura J; Espejo S; Morenate C; Blanco M; Martín P; Medina A; Suárez de Lezo J
Am J Cardiol; 2015 Jun; 115(11):1487-93. PubMed ID: 25851795
[TBL] [Abstract][Full Text] [Related]
12. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients.
Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR
Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843
[TBL] [Abstract][Full Text] [Related]
13. Procedural and one-year clinical outcomes of bioresorbable vascular scaffolds for the treatment of chronic total occlusions: a single-centre experience.
Özel E; Taştan A; Öztürk A; Özcan EE; Kilicaslan B; Özdogan Ö
Cardiovasc J Afr; 2016 Nov/Dec 23; 27(6):345-349. PubMed ID: 27078224
[TBL] [Abstract][Full Text] [Related]
14. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
Maeremans J; Verhaert D; Pereira B; Frambach P; Van Mieghem C; Barbato E; Willems E; Vrolix M; Dens J
Catheter Cardiovasc Interv; 2018 Sep; 92(3):488-496. PubMed ID: 29068171
[TBL] [Abstract][Full Text] [Related]
15. Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study.
Fam JM; Felix C; van Geuns RJ; Onuma Y; Van Mieghem NM; Karanasos A; van der Sijde J; De Paolis M; Regar E; Valgimigli M; Daemen J; de Jaegere P; Zijlstra F; Diletti R
EuroIntervention; 2016 May; 12(1):30-7. PubMed ID: 27173859
[TBL] [Abstract][Full Text] [Related]
16. Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study).
Gheorghe L; Millán X; Jimenez-Kockar M; Gomez-Lara J; Arzamendi D; Danduch L; Agudelo V; Serra A
EuroIntervention; 2019 May; 15(1):99-107. PubMed ID: 30277460
[TBL] [Abstract][Full Text] [Related]
17. Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry).
Ielasi A; Cortese B; Varricchio A; Tespili M; Sesana M; Pisano F; Loi B; Granata F; Moscarella E; Silva Orrego P; La Vecchia L; Steffenino G;
EuroIntervention; 2015 Jun; 11(2):157-62. PubMed ID: 25354760
[TBL] [Abstract][Full Text] [Related]
18. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry.
Kraak RP; Hassell ME; Grundeken MJ; Koch KT; Henriques JP; Piek JJ; Baan J; Vis MM; Arkenbout EK; Tijssen JG; de Winter RJ; Wykrzykowska JJ
EuroIntervention; 2015 Feb; 10(10):1160-8. PubMed ID: 25136885
[TBL] [Abstract][Full Text] [Related]
19. Bioresorbable vascular scaffolds for complex chronic total occlusions.
Yaginuma K; Moehlis H; Koch M; Tischer K; Werner J; Werner GS
Cardiovasc Revasc Med; 2019 Mar; 20(3):220-227. PubMed ID: 30025659
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable vascular scaffold (BVS) for in-stent chronic total occlusion: Antegrade recanalization and IVUS-guided BVS implantation by radial access.
Medda M; Casilli F; Bande M; Latini MG; Ghommidh M; Del Furia F; Inglese L
Cardiovasc Revasc Med; 2016; 17(1):63-5. PubMed ID: 26797428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
